For a study using a combined nomogram integrating independent clinical risk factors, AFP and radiomics signatures with contrast-enhanced MRI, the AUCs were 0.926 (training cohorts) and 0.914 (validation cohorts) for identifying HCC with glypican 3 positivity [31]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.